Company intelligence / Profile preview

BillionToOne

Menlo Park, California, United Statesbilliontoone.com ↗

Ownership: Private
Development stage: Commercial

Overview

BillionToOne has developed a proprietary QCT™ technology that enables highly sensitive detection of disease-associated DNA changes from blood samples. Their UNITY Screen™ has been used in over one million prenatal tests. Their oncology products Northstar Select® and Northstar Response® have received Medicare coverage; clinical validation studies have been published supporting their use in cancer care. The company was named Diagnostics Company of the Year by the BioTech Breakthrough Awards in late 2024.

Therapeutic areas: Women's HealthOncology
Modalities: Cell-free DNA diagnostics (liquid biopsy)Molecular counting technology (QCT™)Genomics-based screening and monitoring
Industry: Molecular Diagnostics

Drug pipeline

3 assets

UNITY Screen

Commercial

Indications: Prenatal genetic screening

2 more assets in the full pipeline.

Request access →

Partnerships

Medicare coverage (payer partnerships)

Beyond the preview

Go deeper on BillionToOne.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BillionToOne.

Explore the full profile